The tablets are available in 100 mg, 150 mg and 200 mg
Dr Reddy’s Laboratories has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg. It is a therapeutic equivalent generic version of Wellbutrin SR (bupropion HCl) sustained-release tablets in the US market approved by the US Food & Drug Administration (US FDA).
The Wellbutrin SR brand and generic had US sales of approximately $109.6 million MAT for the most recent twelve months ending in July 2016 according to IMS Health.
The tablets are available in 100 mg, 150 mg and 200 mg, in bottle count sizes of 60, 100 and 500.